I hold these stock.

DYOH (do your own homework.)

To-day there was a slight drop in price, but number of analysts are giving favourable reports.

What triggered my interest was better than expected results and if I am right looking at charts it shows an inverted head and shoulders. Hopefully a good sign. Also the current rate of Share price growth is about 90% pa over the last 5weeks. This is unlikely to continue indefinitely but SP could hit 850p over next few weeks.

To-day at close, there were some large buys of about 5million shares. 40million approx.

Another trigger for me was the following which should increase earnings.

Aviva to form JV in Taiwan with First FinancialAFX
LONDON (Thomson Financial) - Aviva PLC, the UK's largest insurer, said it has entered into a joint venture with First Financial Holding Co Ltd to sell insurance and pension products in Taiwan. The joint venture company, First-Aviva, will distribute long-term savings and pension products in Taiwan through an exclusive agreement with First Financial's flagship unit, First Commercial Bank. Aviva, which will have a 49 pct stake in the joint venture, added that the initial paid up capital of the new company will be 34 mln stg.First Commercial Bank is Taiwan's second largest bank network, with five mln retail customers, it added.TFN.newsdesk@thomson.comkkb/faj/slm




Date: Wednesday 25 Apr 2007
LONDON (ShareCast) - If the message gets home that Aviva will not bid for Prudential, the stock should rebound strongly, especially if Aviva can sustain its current impressive performance. There is still work to be done but, at 794.5p, the shares are a strong buy says the Independent.
Date: Tuesday 24 Apr 2007
LONDON (ShareCast) - Aviva stood out among the risers on a tough day for blue chip stocks. The life insurer posted an upbeat first quarter statement with brokers pleased with the numbers.



DYOH

:0) Thick scouser syndrome.

JP Morgan Cazenove today reaffirms its overweight investment rating on Aviva PLC (LON:AV.) and raised its price target to 596p (from 584p).

Jefferies International today reaffirms its buy investment rating on Aviva PLC (LON:AV.) and cut its price target to 523p (from 568p).

Broker Forecast - Canaccord Genuity issues a broker note on Aviva PLC

BFN

Canaccord Genuity today reaffirms its buy investment rating on Aviva PLC (LON:AV.) and cut its price target to 550p (from 600p).

--=-=-=

Large institutional buy, Check RNS.




-=-==

Have a look at fundamental projections, but charts don't look that enticing to me.

Yield is nice.

I hold.

Fred - it looks like Oncimmune only floated 2 days ago - so an entry level for AV.

Skinny,

Thanks.


Still holding with overall profit.

W/S

Chart of the week: Watch this breakout

May it be soon and long.

Fitch Ratings has affirmed Aviva's long-term issuer default rating at 'A+' and the core insurance subsidiaries' insurer financial strength ratings at 'AA-'. The outlooks are stable.

Fitch says the ratings reflect Aviva's strong position in the group's key markets, diversification by business line, robust capital position and operational scale. Aviva's ratings also benefit from the group's geographical diversification across the UK, Europe, Canada and Asia.

Fitch says Aviva has strong life insurance market positions in the UK, France, Italy and Spain, and exposure to insurance growth markets in Poland, Turkey and Asia. The group has leading non-life market positions in the UK (1st), Canada (2nd) and France (10th). Aviva's market position in Canada will be strengthened by the group's acquisition of RBC General Insurance Company, which was announced in January.

Deutsche Bank today reaffirms its buy investment rating on Aviva PLC (LON:AV.) and cut its price target to 470p (from 610p).

Bring it on.

Standard Life, Aviva and M & G have announced the suspension of trading in their UK Property Funds. This follows a surge in demand of investors wishing to sell their units following the EU referendum result last week. Property funds are often fairly illiquid, as the assets are tied up in properties with dividends and fees being paid out of rental income. Any unexpected increase in sales requests can trigger such actions and there have been similar situations in the past with property funds.

Full details of the announcements can be found at: -

http://lib.standardlife.com/library/uk/UKRealEstateFundssuspension.pdf

https://uk.avivainvestors.com/content/dam/aviva/aviva-investors/united-kingdom/documents/aipt-suspension-QA.pdf

http://www.mandg.co.uk/investor/funds/prices/property-fund-prices/

StockMarketWire.com
Aviva's frist half operating profits rose by 13% to £1,325 million and the dividend is up 10% at 7.42p per share.

The IFRS profit after tax was £201 million (HY15: £545 million) and Aviva reports a Solvency II capital surplus of £9.5 billion (FY15: £9.7 billion). The Solvency II coverage ratio was 174% (FY15: 180%).

General insurance net written premiums were up 7%6 at £3,991 million (HY15: £3,678 million). Life insurance value of new business was up 7%6 at £583 million (HY15: £534 million). Fund management operating profit rose 48% to £49 million (HY15: £33 million) and UK Life platform AUM rose by 23% to £10.3 billion (FY15: £8.4 billion).

Group chief executive Mark Wilson said: "We are delivering consistent, stable and predictable growth despite challenging market conditions.

"Our UK businesses delivered encouraging results. We are growing in the UK, we are investing in the UK. We like the UK. And we are also benefitting from Aviva's diversity, with 42% of our earnings1 coming from outside of the UK.

"The 10% increase in the dividend, up 32% since 2013, is another step towards our target pay-out ratio of 50% and underpins our confidence in delivering sustainable and growing returns.

"We are continuing to maintain a strong balance sheet, with a solvency ratio of 174%2,3, toward the upper end of our working range.

"Aviva's strong financial position and diversity mean we are well insulated from external events. We have deliberately designed Aviva to be resilient to a low interest rate environment.

"We remain confident in our ability to deliver on our key commitments to grow earnings, cash and dividends."

Panmure Gordon Buy 405.40 525.00 525.00 Retains

03 Feb JP Morgan Cazenove Overweight 492.00 553.00 553.00 Reiterates

02 Feb HSBC Hold 492.00 500.00 500.00 Reiterates

Final Results - PART 1 OF 4

Profit
· Operating profit2,3 up 12% to £3,010 million (2015: £2,688 million4)
· Operating EPS2,3 up 3% to 51.1p (2015: 49.7p4)
· Operating profit and operating EPS exclude the impact of the change in the Ogden discount rate in UK general insurance, which has been classified as an exceptional item
· IFRS profit after tax down 22% to £859 million (2015: £1,097 million4) including the £380 million after-tax charge due to the reduction in the Ogden discount rate

1B1BCapital
· Solvency II capital surplus5 £11.3 billion (2015: £9.7 billion)
· Solvency II coverage ratio5,6 of 189% (2015: 180%)
· Solvency II operating capital generation £3.5 billion
· Net asset value up 6% to 414p per share (2015: 390p4)
· Holding company liquidity7 £1.8 billion (2015: £1.3 billion)

2B2B15BCash
· 2016 total dividend up 12% to 23.3p (2015: 20.8p)
· Dividend pay-out ratio 46% (2015: 42%4), progress towards 50% target
· Cash remittances up 20% to £1,805 million (2015: £1,507 million)

3B3B16BGrowth
· General insurance net written premiums3 up 15% to £8,211 million (2015: £7,171 million)
· Life insurance value of new business up 13% to £1,352 million (2015: £1,192 million)
· Fund management operating profit up 30% to £138 million (2015: £106 million)
· AIMS AUM trebled to £9 billion (2015: £3 billion)
· Total group assets under management up to £450 billion

4B4B17BCombined ratio
· General insurance combined operating ratio 95.2% (2015: 94.6%) excluding the Ogden discount rate impact. Including the Ogden impact, the combined operating ratio was 101.1%.

Nice results.

"Reflecting these results, we are increasing the total dividend per share by 12% to 23.3p."

At the moment, the market like the results.

Panmure Gordon Buy 545.75 525.00 592.00 Retains

Results tomorrow.

INTERIM RESULTS

Profit

· Operating profit up 11% to £1,465 million (HY16: £1,325 million)
· Operating EPS up 15% to 25.8p (HY16: 22.4p)
· IFRS profit after tax £716 million (HY16: £201 million)
Capital

· Solvency II coverage ratio of 193%1 (FY16: 189%)
· Capital surplus £11.4 billion1 (FY16: £11.3 billion)
· Operating capital generation £1.1 billion (HY16: £1.2 billion)
· IFRS net asset value per share 412p (FY16: 414p)
Cash

· Interim dividend up 13% to 8.4p (HY16: 7.42p)
· Cash remittances up 56% to £1,170 million (HY16: £752 million)
· UK Life special remittance of £315 million, on track towards £1 billion target by end 2018 with £565 million total special to date
· Holding company liquidity £1.7 billion2 (February 2017: £1.8 billion)
Growth

· General insurance net written premiums up 11%3 to £4,688 million (HY16: £3,991 million)
· Value of new business up 27%3 to £596 million (HY16: £448 million)
· Aviva Investors fund management operating profit up 45% to £71 million (HY16: £49 million)
· UK Life platform funds up 27% to £16.5 billion (FY16: £13.0 billion)
· Total group assets under management £475 billion (FY16: £450 billion)
Combined ratio
· General insurance combined operating ratio 94.5%4 (HY16: 95.7%)